etoposide has been researched along with Li-Fraumeni Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavallari, GM; Custodio, G; De Moura, J; Doghman, M; Figueiredo, BC; Kavalec, FL; Lalli, E; Rosati, R; Santa Maria, J | 1 |
| Ballard, ET; Dickens, DS; Dothage, JA; Heideman, RL; Jubinsky, PT | 1 |
2 other study(ies) available for etoposide and Li-Fraumeni Syndrome
| Article | Year |
|---|---|
Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage.
Topics: Adult; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Proliferation; Cells, Cultured; Codon, Nonsense; Codon, Terminator; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Etoposide; Female; Fibroblasts; Genotype; Germ-Line Mutation; Heterozygote; Humans; Li-Fraumeni Syndrome; Male; Middle Aged; Pedigree; Phenotype; Polymorphism, Genetic; Tumor Suppressor Protein p53 | 2010 |
Successful treatment of an unresectable choroid plexus carcinoma in a patient with Li-Fraumeni syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Li-Fraumeni Syndrome; Magnetic Resonance Imaging; Neoplasm Metastasis | 2005 |